A brief report on incidence, radiographic feature and prognostic significance of brain MRI changes after anti-PD-1/PD-L1 therapy in advanced non-small cell lung cancer.
Jianjiao NiYue ZhouShengping WangTiantian GuoJie HuQian ChuXi YangLi ChuXiao ChuYida LiZhengfei ZhuPublished in: Cancer immunology, immunotherapy : CII (2021)
Brain MRI aberrations developed after ICI treatment are not uncommon, and their manifestations vary a lot. Patients developing brain MRI aberrations tended to have better prognosis, which needed to be further investigated.
Keyphrases
- advanced non small cell lung cancer
- contrast enhanced
- resting state
- magnetic resonance imaging
- white matter
- end stage renal disease
- diffusion weighted imaging
- functional connectivity
- newly diagnosed
- ejection fraction
- chronic kidney disease
- epidermal growth factor receptor
- copy number
- computed tomography
- gene expression
- multiple sclerosis
- deep learning
- peritoneal dialysis
- patient reported outcomes
- subarachnoid hemorrhage
- bone marrow
- mass spectrometry
- patient reported
- atomic force microscopy
- combination therapy
- high speed